As of 2025-06-15, the Intrinsic Value of Indraprastha Medical Corporation Ltd (INDRAMEDCO.NS) is 235.54 INR. This INDRAMEDCO.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 408.35 INR, the upside of Indraprastha Medical Corporation Ltd is -42.30%.
The range of the Intrinsic Value is 197.17 - 302.89 INR
Based on its market price of 408.35 INR and our intrinsic valuation, Indraprastha Medical Corporation Ltd (INDRAMEDCO.NS) is overvalued by 42.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 197.17 - 302.89 | 235.54 | -42.3% |
| DCF (Growth 10y) | 224.63 - 340.79 | 267.37 | -34.5% |
| DCF (EBITDA 5y) | 386.07 - 516.53 | 448.28 | 9.8% |
| DCF (EBITDA 10y) | 351.09 - 512.89 | 423.51 | 3.7% |
| Fair Value | 439.05 - 439.05 | 439.05 | 7.52% |
| P/E | 379.69 - 673.32 | 480.03 | 17.6% |
| EV/EBITDA | 397.74 - 523.61 | 450.57 | 10.3% |
| EPV | 163.82 - 208.53 | 186.18 | -54.4% |
| DDM - Stable | 84.87 - 191.58 | 138.23 | -66.2% |
| DDM - Multi | 112.09 - 197.47 | 143.07 | -65.0% |
| Market Cap (mil) | 37,433.44 |
| Beta | 1.52 |
| Outstanding shares (mil) | 91.67 |
| Enterprise Value (mil) | 34,543.54 |
| Market risk premium | 8.31% |
| Cost of Equity | 14.87% |
| Cost of Debt | 14.31% |
| WACC | 14.83% |